Correlation Between VTv Therapeutics and Accenture Plc

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VTv Therapeutics and Accenture Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VTv Therapeutics and Accenture Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between vTv Therapeutics and Accenture plc, you can compare the effects of market volatilities on VTv Therapeutics and Accenture Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VTv Therapeutics with a short position of Accenture Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of VTv Therapeutics and Accenture Plc.

Diversification Opportunities for VTv Therapeutics and Accenture Plc

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between VTv and Accenture is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding vTv Therapeutics and Accenture plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Accenture plc and VTv Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on vTv Therapeutics are associated (or correlated) with Accenture Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Accenture plc has no effect on the direction of VTv Therapeutics i.e., VTv Therapeutics and Accenture Plc go up and down completely randomly.

Pair Corralation between VTv Therapeutics and Accenture Plc

Given the investment horizon of 90 days vTv Therapeutics is expected to generate 2.32 times more return on investment than Accenture Plc. However, VTv Therapeutics is 2.32 times more volatile than Accenture plc. It trades about 0.25 of its potential returns per unit of risk. Accenture plc is currently generating about -0.18 per unit of risk. If you would invest  2,159  in vTv Therapeutics on January 25, 2024 and sell it today you would earn a total of  339.00  from holding vTv Therapeutics or generate 15.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

vTv Therapeutics  vs.  Accenture plc

 Performance 
       Timeline  
vTv Therapeutics 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in vTv Therapeutics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, VTv Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Accenture plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Accenture plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in May 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

VTv Therapeutics and Accenture Plc Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VTv Therapeutics and Accenture Plc

The main advantage of trading using opposite VTv Therapeutics and Accenture Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VTv Therapeutics position performs unexpectedly, Accenture Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Accenture Plc will offset losses from the drop in Accenture Plc's long position.
The idea behind vTv Therapeutics and Accenture plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk